found a HDAC6 inhibitor, CKD-504, which could dramatically change the tau interactome to degrade pathological tau in amyloid plaques and neurofibrillary tangles of AD model mouse brains through the proteasomal pathway, in the end rescuing cognitive decline in AD model mice (138). This evidence concerns the gene HDAC6 and Alzheimer disease.